Renowned Jamaican scientist, Professor Henry Lowe, whose research led to the discovery of a new cancer drug treatment, has been invited to make a special presentation at the Eighth Annual Congress of International Drug Discovery Science and Technology (IDDST) next month in Beijing, China.

Lowe's presentation will be on research work on Jamaican medicinal plants, parti-cularly his recent work with Tillandsia recurvata, otherwise called ball moss, which has demonstrated potent anti-cancer activities during testing.

The IDDST Congress, which is being held October 23-25, is considered to be a leading international event that highlights scientific and technological breakthroughs, and will focus on bringing the next blockbuster drug to market.

While in Beijing, Lowe will have the opportunity to meet with pharmaceutical executives and tour pharmaceutical facilities for collaborative research development work.

Earlier this year, Lowe was granted a United States patent to conduct further research on the development of the drug.

The drug, which is now in its final stages of development, is said to be equal to or better than most types of anti-cancer drugs.

Lowe, who is executive chairman of the Environmental Health Foundation, is also distinguished adjunct professor of ethno-medicinal chemistry at the University of Technology, as well as adjunct professor in the Department of Medicine, University of Maryland.

He is also a senior research fellow at the University of the West Indies, Mona.

In February of this year, Lowe was granted special residency in the US under the category of 'Alien of Extraordinary Ability (in Science)', joining a very distinguished group of internationally honoured scientists.